Methylprednisolone Tablets USP — Class III drug recall D-0298-2021
Terminated recall by Jubilant Cadista Pharmaceuticals, Inc., reported 2021-03-10, distributed nationwide. Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructio
| Recall number | D-0298-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, United States |
| Recall initiated | 2021-02-19 |
| Classified | 2021-03-04 |
| Reported by FDA | 2021-03-10 |
| Terminated | 2022-11-15 |
| Distributed | Nationwide (US) |
| Quantity | 635,400 cartons |
| Reason classes | labeling |
| NDC | 59746-0001-03 |
| Lot numbers | 20K0042P, 20K0043P, 20K0044P, 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P |
| Expiration dates | 2022-08, 2022-09 |
Product
Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03
Reason for recall
Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0298-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.